| Recruiting | IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia. Acute Myeloid Leukemia, Relapse/Recurrence | Phase 3 | 2025-02-27 |
| Recruiting | Sequential Immunochemotherapy Treatment with Pembrolizumab Plus Dendritic Cell (DC) Vaccine Followed by Triflu Colorectal Cancer Metastatic, Microsatellite Stable Colorectal Carcinoma, Refractory Mismatch-repair-proficient (pMMR) Metastatic Colorectal Cancer | Phase 2 | 2025-01-07 |
| Recruiting | Master Framework For Relapse or Refractory Acute Myeloid Leukemia Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory | — | 2024-06-28 |
| Terminated | Avidination for RadionuclideTHerapy in Nonpalpable Breast Cancer Breast Cancer | Phase 1 | 2024-06-19 |
| Recruiting | Whole Body MRI in Oncology Lymphoma, Advanced Prostate Cancer, Advanced Breast Cancer | — | 2023-10-26 |
| Recruiting | "Receptor Radionuclide Therapy With 177Lu-DOTATOC Neuroendocrine Tumors, Paraganglioma, Pheochromocytoma | Phase 2 | 2023-09-13 |
| Unknown | 68 Gallium-Fibroblast Activating Protein Inhibitors-46 Positron Emission Tomography - Computerized Tomography Solid Tumor, Unspecified, Adult | Phase 2 | 2023-08-21 |
| Recruiting | Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST) Prostate Cancer | Phase 2 | 2023-06-27 |
| Withdrawn | GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2023-06-14 |
| Active Not Recruiting | Radiometabolic Therapy With 177Lu PSMA in PSMA PET/CT Positive Advanced/Metastatic Tumours: Cancer | Phase 2 | 2023-05-25 |
| Recruiting | Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer Previously Treated with C Breast Cancer, Recurrent | Phase 2 | 2023-03-31 |
| Recruiting | Pembrolizumab and Olaparib Treatment of Extensive Small Cell Lung Cancer (ES-SCLC) SCLC,Extensive Stage | Phase 2 | 2023-03-27 |
| Unknown | Prehabilitation in Geriatric Patients With Colorectal Neoplasia Colo-rectal Cancer | N/A | 2023-03-22 |
| Completed | Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC) Metastatic Castration Resistant Prostate Cancer, 68Ga-PSMA PET/CT Positive | Phase 2 | 2022-10-25 |
| Unknown | Effects of Nurse-led Telephone Based Service for Early Palliative Care (PALTEL) Palliative Care, Cancer | N/A | 2022-09-01 |
| Completed | Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in Oncohematology Cancer, Solid Tumor, Hematologic Malignancy | N/A | 2021-05-04 |
| Recruiting | Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma Glioblastoma, Vaccination | Phase 2 | 2021-03-25 |
| Terminated | The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Mem Metastatic Castration Resistant Prostate Cancer (mCRPC) | — | 2021-02-01 |
| Completed | Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventi Cancer, Chronic Renal Failure, Chronic Obstructive Pulmonary Disease | — | 2020-12-14 |
| Completed | Key Performance Indicators for the Assessment of NSCLC Patients Pathway Non Small Cell Lung Cancer | — | 2020-10-01 |
| Recruiting | InteGRAtive Analysis of TuMor, Microenvironment, ImmunitY and Patient Expectation for Personalized Response Pr Gastric Cancer | — | 2020-09-22 |
| Completed | Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients 18F-PSMA, Prostate Cancer | Phase 2 | 2020-07-31 |
| Terminated | Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID- COVID19, Hydroxychloroquine, Prophylaxis | Phase 2 | 2020-05-14 |
| Recruiting | Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL) Diffuse Large B Cell Lymphoma | — | 2020-05-14 |
| Unknown | Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respira COVID-19, SARS-CoV-2 | — | 2020-03-27 |
| Recruiting | What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer? Breast Cancer | N/A | 2020-02-06 |
| Unknown | Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies Haematologic Disease, Haematological Malignancy | — | 2020-01-07 |
| Recruiting | A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resec Head Neck Tumors, Neuroendocrine Tumors, Soft Tissue Sarcoma | Phase 2 | 2019-12-12 |
| Active Not Recruiting | Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Mesothelioma, Malignant, PD-L1 Negative, Advanced Cancer | Phase 1 | 2019-12-12 |
| Completed | ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjuga Acute Lymphoblastic Leukemia | — | 2019-11-27 |
| Recruiting | "Triple Negative" Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALL Leukemia, Lymphoblastic | — | 2019-10-23 |
| Unknown | Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting BCL Acute Myeloid Leukemia | — | 2019-08-23 |
| Unknown | Yoga on QOL Physiological Distress&Fatigue, on Patients Affected by Breast Cancer in Adjuvant Radiotherapy Female Breast Cancer, Fatigue, Quality of Life | N/A | 2019-08-02 |
| Active Not Recruiting | Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leuk Acute Myeloid Leukemia | — | 2019-07-19 |
| Completed | Acupuncture And Inflammatory Status In Breast Cancer Patients With Climateric Syndrome. Breast Cancer | — | 2019-07-02 |
| Completed | Medication Reconciliation in Oncologic Patients Medication Reconciliation | N/A | 2019-06-12 |
| Unknown | Emilia-Romagna Surgical Colorectal Cancer Audit- ESCA Financial Benefit, Colorectal Cancer, Surgery | — | 2019-04-16 |
| Completed | Skin Toxicity by Oncological Therapies Skin Toxicity | — | 2019-03-21 |
| Terminated | Twice High Dose External Beam Radiotherapy by Image-guided Tomotherapy for Organ-confined Prostate Cancer Trea Prostate Adenocarcinoma, Radiotherapy; Complications, Tomotherapy | N/A | 2018-10-30 |
| Unknown | Italian Non-Interventional Study of FLT3 Mutated AML Patients AML, FLT3-ITD Mutation, FLT3-TKD Mutation | — | 2018-07-18 |
| Terminated | Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging. 68Ga-PSMA PET/CT Guided Prostate Biopsy, Mp-3TMRI Guided Prostate Biopsy, Prostate Cancer | N/A | 2018-05-23 |
| Unknown | Accelerated Hypofractionated Intensity - Modulated Radiotherapy After Hyperbaric Oxygenation for Recurrent Hig Malignant Glioma, High Grade Glioma, Recurrent Glioma | N/A | 2018-02-22 |
| Active Not Recruiting | Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cance Metastatic Castration-resistant Prostate Cancer | Phase 2 | 2017-09-01 |
| Active Not Recruiting | Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma Malignant Pleural Mesothelioma | N/A | 2017-08-14 |
| Completed | CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDO Hormone Receptor Positive Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Negative Breast Cancer | Phase 2 | 2017-08-02 |
| Completed | Investigation of PSMA PET/CT as an Imaging Biomarker in Solid Tumors Prostate-specific Membrane Antigen, mCRPC or Advanced/Metastatic Solid Tumors | N/A | 2017-07-04 |
| Terminated | CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas Neuroendocrine Carcinoma | Phase 2 | 2017-03-06 |
| Terminated | Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle DLBCL, MCL, Recurrent Disease | Phase 2 | 2016-12-22 |
| Recruiting | Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection Stage IV Colorectal Cancer, Curative Resection | Phase 2 | 2016-12-02 |
| Active Not Recruiting | Optimizing the Interval Between Cycles of PRRT with 177lu-dotatate in Sstr2 Positive Tumors Neuroendocrine Tumors | Phase 2 | 2016-05-26 |
| Terminated | 177Lutethium - Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positiv Gastro-entero-pancreatic Neuroendocrine Tumors | Phase 2 | 2016-05-01 |
| Terminated | Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Carcinoma, Non-Small-Cell Lung, Secondary, Advanced Stage IIIB | Phase 2 | 2016-03-01 |
| Withdrawn | Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immuno Carcinoma, Renal Cell, Vaccination, Secondary | Phase 2 | 2016-03-01 |
| Unknown | Italian Study Of Validation Of Angiogenesis Polymorphisms In HCC Patients Treated With Sorafenib Hepatocellular Carcinoma | — | 2016-02-15 |
| Unknown | Participatory Research for Fine-tuning of a 2.0 System to Optimise Home Management of Oral Cancer Therapies. Cancer, Oral Drug Administration | N/A | 2016-01-27 |
| Completed | Prospective Observational Study Comparing Calcium and Sodium Levofolinate in Combination With 5-Fluorouracil ( Gastrointestinal Cancer, CALCIUM LEVOFOLINATO (Ca-lev), SODIUM LEVOFOLINATO (Na-lev) | — | 2015-11-03 |
| Completed | Implementing an Evidence-based Computerized Decision Support System Linked to Electronic Health Records to Imp Medical Oncology | N/A | 2015-11-01 |
| Completed | 68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Canc 68Ga-PSMA HBED-PET/CT, Prostate Cancer | N/A | 2015-11-01 |
| Terminated | PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKI Metastatic Renal Cancer | Phase 2 | 2015-09-22 |
| Terminated | 3 Tesla Magnetic Resonance Guided High Intensity Focused Ultrasound in the Treatment of Pain From Bone Metasta Solid Tumors | N/A | 2015-09-14 |
| Completed | Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor Neoplasms, Germ Cell and Embryonal | Phase 2 | 2015-09-11 |
| Completed | Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Neuroendocrine Tumors, Gastro Entero Pancreatic Neuroendocrine Tumors | Phase 1 / Phase 2 | 2015-09-02 |
| Terminated | Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and I Malignant Melanoma, Adjuvant Drug Therapy, Vaccin Therapy | Phase 2 | 2015-08-01 |
| Terminated | Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell Lung Cancer With MGMT Methyla Small Cell Lung Cancer Recurrent | Phase 2 | 2015-01-01 |
| Completed | A Study of Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positiv HER-2 Positive Breast Cancer | Phase 2 | 2014-12-17 |
| Unknown | CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC. Prostate Cancer, Metastatic Cancer, Castration-resistant Prostate Cancer | — | 2014-12-15 |
| Terminated | Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE in Advanced Gastro-entero Pancreatic Neuroend Neuroendocrine Tumors | Phase 2 | 2013-12-01 |
| Completed | Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carci Rectal Carcinoma | Phase 2 | 2013-10-11 |
| Recruiting | National Database of Bone Metastases Bone Metastases | — | 2013-10-08 |
| Completed | Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Im Malignant Melanoma of Skin Stage III, Malignant Melanoma of Skin Stage IV | Phase 2 | 2013-10-08 |
| Terminated | A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopaus Metastatic Breastcancer, Estrogen Receptor Positive Breast Cancer, Estrogen Receptor Negative Neoplasm | Phase 2 | 2013-03-01 |
| Completed | Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC Non-small Cell Lung Cancer Metastatic | Phase 4 | 2012-10-01 |
| Completed | The Role of Early Systematic Best Palliative Care Versus on Request Palliative Care Consultation During Standa Pancreatic Neoplasm, Gastric Neoplasm | N/A | 2012-08-01 |
| Completed | Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated Metastatic Renal Cell Cancer, Malignant Melanoma, Metastatic | Phase 2 | 2012-07-09 |
| Completed | Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colore Colorectal Cancer Metastatic | Phase 2 | 2012-07-01 |
| Completed | Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonme Unresectable Pancreatic Cancer, Nonmetastatic Pancreatic Cancer, Locally Advanced Pancreatic Cancer | Phase 2 | 2010-11-01 |
| Completed | Pre-Operative Or Peri-Operative Dox Regimen In Patients With Locally Advanced Resectable Gastric Cancer Gastric Cancer, Locally Advanced Malignant Neoplasm | Phase 2 | 2010-09-01 |
| Completed | A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every Women With Primary Breast Cancer | Phase 2 | 2010-09-01 |
| Completed | Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastat Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Phase 2 | 2010-09-01 |
| Terminated | A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Canc HER-2 Positive Breast Cancer, Malignant Neoplasm of Breast | Phase 1 | 2009-12-01 |
| Completed | Sequential Treatment Strategy for Metastatic Colorectal Cancer Metastatic Colorectal Cancer | Phase 3 | 2007-11-01 |
| Unknown | Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Breast Cancer | Phase 3 | 1997-11-01 |